StockData

Guardian Pharmacy Services vs 111

GRDN and YI side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GRDN and YI compare

Guardian Pharmacy Services grew revenue faster over the last twelve months (4.9% versus −12.8% for 111).

Guardian Pharmacy Services scores higher on the StockData Score (9 against 3 for 111), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGRDNYI
Size and price
Market cap$3.2B–
Share price$49.98$2.93
Change, 1 year68.0%−28.7%
Change, 5 years–−94.0%
Beta (5Y)0.561.16
Employees3,600144
StockData Score
Total score9 (better)3
Valuation score00
Growth score2 (better)1
Performance score1 (better)0
Health score6 (better)2
Dividend score00
Valuation
P/S2.2×–
EV/EBITDA26.0×–
Fair value$19.44–
Margin of safety−157%–
Growth
Revenue growth (TTM)4.9% (better)−12.8%
Revenue growth, 5Y average–8.9%
Net income growth (TTM)85.8%–
Profitability
Gross margin22.4% (better)5.8%
Operating margin6.5% (better)−0.02%
Net margin5.1%–
FCF margin–0.91%
Financial health
Net debt / EBITDA–−39.46
Interest coverage145× (better)−0.1×
Current ratio1.65 (better)1.09
Altman Z-score13.18–
Piotroski F-score7–
Dividends and buybacks
Buyback yield−0.96%–
Shareholder yield−0.96%–
Ownership
Held by institutions46.6%0.01%
Held by insiders43.6%21.8%
Insider net buying, 12 months−$419M−$369K (better)
Short interest, % of float6.2%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.